Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
First malaria saliva test identifies malaria parasites20 March, 2019Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were... -
Oral levofloxacin and intravenous vancomycin for bacteraemia due to Microbacterium paraoxydans13 March, 2019A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin... -
Levofloxacin for lower lobe pneumonia presenting as persistent hiccups7 March, 2019Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory... -
2018 Taiwan’s pneumonia guidelines: What’s new?4 March, 2019Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief,... -
Progress against malaria stalls28 February, 2019Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and an estimated 219... -
Oral sitafloxacin as a switch therapy for the treatment of non-bacteraemic acute pyelonephritis21 February, 2019A treatment regimen of carbapenem followed by sitafloxacin or ertapenem was found to be effective in patients with non-bacteraemic acute pyelonephritis caused by extended-spectrum... -
Managing mycobacterial infection after lung transplantation with levofloxacin: Case series11 February, 2019The combination of levofloxacin with isoniazid, pyrazinamide and ethambutol was found to be effective in managing mycobacterial infection in lung transplant recipients. The risk of... -
Can India eliminate TB by 2025?25 January, 2019India accounts for 27% of the estimated 10 million tuberculosis (TB) cases worldwide, and 26% of the 6.4 million new cases of TB reported in 2017 – making it one of the 30 countries with high... -
Levofloxacin improves spondylitis complication in Escherichia coli endocarditis18 January, 2019A two-month course of levofloxacin (500 mg/day) resolved purulent spondylitis in a patient with Escherichia coli infective endocarditis (IE). A 58-year old Japanese woman presented with... -
Ceftriaxone plus levofloxacin for the treatment of Streptococcus intermedius pleuropulmonary infection11 January, 2019Ceftriaxone–levofloxacin combination is the most frequently used antimicrobial for the treatment of Streptococcus intermedius pleuropulmonary infection; drainage of pleural effusion and other...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
2018 Taiwan’s pneumonia guidelines: What’s new? -
Interview with Prof Wang Minggui -
Levofloxacin for the Management of Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia (Interview with Prof. Marin H. Kollef) -
The Use of Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (Interview with Prof. Hartmut Lode) -
Effect of Combination of Levofloxacin and Meropenem against Pseudomonas aeruginosa (Supervised by Prof. Kazuhiro Tateda, MD, PhD) -
Viewing Infectious Respiratory Disease (Supervised by Prof. Jiro Fujita, MD, PhD, ACCP) -
New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts) -
New Era for the Treatment of Respiratory Tract infections (Daiichi Pharmaceutical Co., Ltd., Special Interview) -
The Efficacy, Tolerability, and Benefits of 750 mg Once-Daily Levofloxacin in the Treatment of Community-Acquired Pneumonia (Interview with Prof. Thomas M. File, Jr, MD, MS ) -
Smarter Therapy: Guidelines for Optimal Management of Neutropenic Cancer Patients (Interview with Professor Thomas M. File, Jr.)
UPCOMING EVENTS
05 June - 09 June, 2019
Washington, DC, USA, North America
07 July - 12 July, 2019
Glasgow, United Kingdom, Western Europe
16 September - 20 September, 2019
Liverpool, UK, Western Europe
